[go: up one dir, main page]

TW200624431A - Phthalazinone derivatives, their manufacture and use as pharmaceutical agents - Google Patents

Phthalazinone derivatives, their manufacture and use as pharmaceutical agents

Info

Publication number
TW200624431A
TW200624431A TW094132585A TW94132585A TW200624431A TW 200624431 A TW200624431 A TW 200624431A TW 094132585 A TW094132585 A TW 094132585A TW 94132585 A TW94132585 A TW 94132585A TW 200624431 A TW200624431 A TW 200624431A
Authority
TW
Taiwan
Prior art keywords
manufacture
pharmaceutical agents
phthalazinone derivatives
compounds
mentioned compounds
Prior art date
Application number
TW094132585A
Other languages
English (en)
Inventor
Edward Boyd
Frederick Brookfield
Guy Georges
Bernhard Goller
Sabine Huensch
Petra Rueger
Matthias Rueth
Christine Schuell
Der Saal Wolfgang Von
Justin Warne
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of TW200624431A publication Critical patent/TW200624431A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW094132585A 2004-09-24 2005-09-21 Phthalazinone derivatives, their manufacture and use as pharmaceutical agents TW200624431A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04022755 2004-09-24

Publications (1)

Publication Number Publication Date
TW200624431A true TW200624431A (en) 2006-07-16

Family

ID=34926696

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094132585A TW200624431A (en) 2004-09-24 2005-09-21 Phthalazinone derivatives, their manufacture and use as pharmaceutical agents

Country Status (16)

Country Link
US (1) US7226923B2 (zh)
EP (1) EP1794148B1 (zh)
JP (1) JP2008514564A (zh)
KR (1) KR100907202B1 (zh)
CN (1) CN101027290B (zh)
AR (1) AR050948A1 (zh)
AT (1) ATE428708T1 (zh)
AU (1) AU2005287458A1 (zh)
BR (1) BRPI0515885A (zh)
CA (1) CA2580198A1 (zh)
DE (1) DE602005013985D1 (zh)
ES (1) ES2323885T3 (zh)
MX (1) MX2007003104A (zh)
RU (1) RU2397166C2 (zh)
TW (1) TW200624431A (zh)
WO (1) WO2006032518A1 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006055831A2 (en) 2004-11-17 2006-05-26 Miikana Therapeutics, Inc. Kinase inhibitors
ES2535854T3 (es) 2005-09-30 2015-05-18 Miikana Therapeutics, Inc. Compuestos de pirazol sustituidos
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
EP1998777A1 (en) * 2006-03-20 2008-12-10 F. Hoffmann-La Roche AG Methods of inhibiting btk and syk protein kinases
CA2645728A1 (en) * 2006-03-20 2007-09-27 Edward Boyd (Deceased) Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agents
WO2008004088A2 (en) * 2006-07-05 2008-01-10 Centre National De La Recherche Scientifique (C.N.R.S.) Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding
GB0619342D0 (en) * 2006-09-30 2006-11-08 Vernalis R&D Ltd New chemical compounds
SG175609A1 (en) 2006-10-09 2011-11-28 Takeda Pharmaceutical Kinase inhibitors
DE102008000872A1 (de) 2007-04-11 2008-11-13 Basf Se Fungizide Pyridazine, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Schadpilzen sowie sie enthaltende Mittel
US9464079B2 (en) 2011-03-23 2016-10-11 Semorex Technologies Ltd. Treatment of proliferative disorders with a chemiluminescent agent
JP5934787B2 (ja) * 2011-05-10 2016-06-15 ギリアード サイエンシーズ， インコーポレイテッド イオンチャネルモジュレーターとしての縮合複素環式化合物
UY34171A (es) 2011-07-01 2013-01-31 Gilead Sciences Inc Compuestos heterocíclicos fusionados como moduladores del canal iónico
NO3175985T3 (zh) 2011-07-01 2018-04-28
AU2014243818B2 (en) 2013-03-13 2017-04-20 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis
CN105873900B (zh) 2013-12-18 2018-11-30 孟山都技术公司 用于使2,5-二氯苯胺重氮化的方法
WO2016130460A2 (en) * 2015-02-09 2016-08-18 The Johns Hopkins University Phthalazinone pyrazole derivatives for treating retinal degenerative disease
WO2017003723A1 (en) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
RU2674761C2 (ru) * 2016-12-21 2018-12-13 федеральное государственное бюджетное образовательное учреждение высшего образования "Тольяттинский государственный университет" Способ получения анилина и катализатор для него
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
CN108250150B (zh) * 2018-03-15 2020-12-29 兰州大学 一种肽嗪酮化合物及其制备方法与应用
CN111039940B (zh) * 2019-12-31 2022-10-21 北京鑫开元医药科技有限公司 一种Aurora A激酶抑制剂、制备方法、药物组合物及其用途
CN113773263B (zh) * 2020-06-10 2023-09-19 兰州大学 一种4-胺取代酞嗪酮极光激酶b抑制剂及其制备与应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700823A (en) 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5736534A (en) 1994-02-23 1998-04-07 Pfizer Inc. 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents
DK0868519T3 (da) 1995-12-18 2006-05-08 Sugen Inc Diagnose og behandling af AUR-1- og/eller AUR-2-relaterede lidelser
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
ZA986729B (en) 1997-07-29 1999-02-02 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
ITMI981671A1 (it) 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodisterasi 4
US6180629B1 (en) * 1998-08-14 2001-01-30 Cell Pathways, Inc. [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
UA71945C2 (en) 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
SI1154774T1 (en) 1999-02-10 2005-10-31 Astrazeneca Ab Quinazoline derivatives as angiogenesis inhibitors
GB9922171D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
IL148489A0 (en) 1999-09-21 2002-09-12 Astrazeneca Ab Quinazoline compounds and pharmaceutical compositions containing them
CA2384291A1 (en) 1999-09-21 2001-03-29 Astrazeneca Ab Quinazoline derivatives and their use as pharmaceuticals
GB9922173D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
JP2003520855A (ja) 2000-01-28 2003-07-08 アストラゼネカ アクチボラグ 化学的化合物
NZ521421A (en) 2000-04-07 2004-09-24 Astrazeneca Ab Quinazoline compounds
ATE326459T1 (de) 2000-09-15 2006-06-15 Vertex Pharma Pyrazolverbindungen als protein-kinasehemmer
CN100408573C (zh) * 2000-12-21 2008-08-06 沃泰克斯药物股份有限公司 可用作蛋白激酶抑制剂的吡唑化合物
ES2274035T3 (es) 2001-06-01 2007-05-16 Vertex Pharmaceuticals Incorporated Compuestos de tiazol utiles como inhibidores de proteina quinasas.
KR100957516B1 (ko) 2001-08-15 2010-05-14 이코스 코포레이션 2ｈ-프탈라진-1-온 및 이것의 사용 방법
DK1463506T3 (da) 2001-12-24 2010-01-11 Astrazeneca Ab Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser
CN1627944A (zh) * 2002-01-17 2005-06-15 神经能质公司 取代的喹唑啉－4－基胺类似物作为辣椒辣素调节剂
DE60332433D1 (de) 2002-03-15 2010-06-17 Vertex Pharma Azolylaminoazine als proteinkinasehemmer
US20040009981A1 (en) 2002-03-15 2004-01-15 David Bebbington Compositions useful as inhibitors of protein kinases
US6846928B2 (en) 2002-03-15 2005-01-25 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
WO2003078426A1 (en) 2002-03-15 2003-09-25 Vertex Pharmaceuticals, Inc. Azolylaminoazine as inhibitors of protein kinases
MY141867A (en) 2002-06-20 2010-07-16 Vertex Pharma Substituted pyrimidines useful as protein kinase inhibitors
US7361665B2 (en) 2002-07-09 2008-04-22 Vertex Pharmaceuticals Incorporated Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

Also Published As

Publication number Publication date
RU2007115161A (ru) 2008-11-10
ATE428708T1 (de) 2009-05-15
AR050948A1 (es) 2006-12-06
RU2397166C2 (ru) 2010-08-20
MX2007003104A (es) 2007-06-07
DE602005013985D1 (de) 2009-05-28
KR100907202B1 (ko) 2009-07-10
CN101027290A (zh) 2007-08-29
BRPI0515885A (pt) 2008-08-12
US20060089359A1 (en) 2006-04-27
WO2006032518A1 (en) 2006-03-30
EP1794148A1 (en) 2007-06-13
AU2005287458A1 (en) 2006-03-30
ES2323885T3 (es) 2009-07-27
CA2580198A1 (en) 2006-03-30
US7226923B2 (en) 2007-06-05
EP1794148B1 (en) 2009-04-15
KR20070046193A (ko) 2007-05-02
CN101027290B (zh) 2010-05-12
JP2008514564A (ja) 2008-05-08

Similar Documents

Publication Publication Date Title
TW200730502A (en) Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
TW200635923A (en) Tricyclic heterocycles, their manufacture and use as pharmaceutical agents
TW200624431A (en) Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
MX2009002010A (es) Derivados de heteroarilo como inhibidores de la proteina cinasa.
WO2006066913A3 (en) Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors
ATE499372T1 (de) Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
WO2006066914A3 (en) Carbamate substituted imidazo- and pyrrolo-pyridines as protein kinase inhibitors
TW200639156A (en) New compounds
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
TW200719899A (en) Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents
IL191748A0 (en) 7h-pyrido[3,4-d]pyrimidin-8-ones, their manufacture and use as protein kinase inhibitors
TW200531688A (en) Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
MX2008011769A (es) Derivados de ftalazinona pirazol, su fabricacion y uso como agentes farmaceuticos.
IL198630A0 (en) Pyrimidyl derivatives as protein kinase inhibitors
TW200736220A (en) Pyridylsulfonamide derivatives, their manufacture and use as pharmaceutical agents
TW200720239A (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
TW200505913A (en) Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
TW200738680A (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
MXPA05011671A (es) Nuevos derivados de anilina, su manufactura y su uso como agentes farmaceuticos.
TW200612914A (en) Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
TW200633701A (en) Thioether derivatives, their manufacture and use as pharmaceutical agents
TW200602329A (en) Novel diazine derivatives, their manufacture and use as pharmaceutical agents
WO2005016921A3 (en) Novel oxazoles, their manufacture and use as pharmaceutical agents
TW200626149A (en) Tricycles, their manufacture and use as pharmaceutical agents
TW200626589A (en) Azole derivatives, their manufacture and use as pharmaceutical agents